Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“This week I had the privilege of joining the global hemophilia community at the World Federation of Hemophilia World Congress in Kuala Lampur, Malaysia.
The meeting was nothing short of inspiring—being in the room with clinicians, researchers, patient advocates and people living with hemophilia from around the world was a powerful reminder of why our work matters.
At Sanofi, we remain committed to advancing care for people with rare blood disorders, and moments like these continue to reinforce our team’s sense of urgency and purpose.
I’m grateful for the connections and conversations and look forward to what’s ahead.”
Stay updated with Hemostasis Today.
-
Jun 16, 2026, 17:36Suhasini Sil: Mitigating Grade III Plateletpheresis Reactions – A Prospective Evaluation
-
Jun 16, 2026, 17:32Presenting Pivotal Phase 3 Sickle Cell Data at EHA 2026- Agios Pharmaceuticals
-
Jun 16, 2026, 16:17Megan Lynch: Thrilled to Join AstraZeneca
-
Jun 16, 2026, 16:00Denise M: Two Partners, One Mission – Securing the Future of Blood
-
Jun 16, 2026, 15:4910 Posts Not To Miss From EHA 2026
-
Jun 16, 2026, 15:48Yan Leyfman: Can a Blood Test Reveal which Cells in Your Body are Aging Fastest?
-
Jun 16, 2026, 15:24Hiteshi K.C. Chauhan: Oral Anticoagulant Reversal in Major Bleeding and Urgent Surgery
-
Jun 16, 2026, 14:50Abdulrahman Nasiri: Honored to Share our Research Contributions at the EHA 2026
-
Jun 16, 2026, 14:49An Overview of Bernard–Soulier Syndrome – ICHCC